Zeo ScientifiX, Inc. (ZEOX)
OTCMKTS · Delayed Price · Currency is USD
1.870
-0.130 (-6.50%)
Oct 31, 2025, 4:00 PM EDT
Zeo ScientifiX Revenue
Zeo ScientifiX had revenue of $1.31M in the quarter ending July 31, 2025, with 19.71% growth. This brings the company's revenue in the last twelve months to $4.79M, down -0.19% year-over-year. In the fiscal year ending October 31, 2024, Zeo ScientifiX had annual revenue of $4.62M with 1.36% growth.
Revenue (ttm)
4.79M
Revenue Growth
-0.19%
P/S Ratio
2.57
Revenue / Employee
239.45K
Employees
20
Market Cap
12.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 31, 2024 | 4.62M | 62.00K | 1.36% |
| Oct 31, 2023 | 4.56M | -1.93M | -29.78% |
| Oct 31, 2022 | 6.49M | 893.52K | 15.96% |
| Oct 31, 2021 | 5.60M | 2.54M | 83.18% |
| Oct 31, 2020 | 3.06M | 1.35M | 79.51% |
| Oct 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |
Zeo ScientifiX News
- 9 days ago - ZEO ScientifiX(TM) Positioned for New Growth as Florida Opens Stem Cell Market - Accesswire
- 4 months ago - ZEO ScientifiX Positions for National Growth as Stem Cell Market Opens in Florida - Accesswire
- 4 months ago - ZEO ScientifiX Launches Physician-Focused Masterclass Ahead of Florida's SB-1768 Law Implementation - Accesswire
- 9 months ago - ZEO ScientifiX Strengthens Leadership Team With The Appointment of Dr. Peter Everts as Chief Scientific and Technology Officer - Accesswire
- 9 months ago - ZEO ScientifiX Provides Business Update to Stockholders and the Investment Community - Accesswire
- 1 year ago - ZEO ScientifiX and Exotropin Join Forces to Launch a Solution to Address the Growing Unmet Need for Hair Loss - Accesswire
- 1 year ago - ZEO ScientifiX, a Leading South Florida Biotechnology Company, Launches Regenerative Medicine Educational Series for Physicians - Accesswire
- 1 year ago - ZEO ScientifiX Partners with National Provider of Healthcare Services - Accesswire